Free Trial

Vaccine News Prompts Steeper Rate Path

NORGES BANK
  • A steeper path from Norges Bank, most sell-side has seen only minor tweaks but this is more sizeable and brings forward first hike by about six months.
  • Bank pins the rate path tweak largely on vaccine news: "Vaccine availability will likely speed up the recovery through 2021 compared with that projected in the September Report."
  • EUR/NOK on session lows and testing levels last seen late November.
Sept. ProjectionsDec. ProjectionsChange (bps)
31/12/20200.000.00-
31/03/20210.000.00-
30/06/20210.000.00-
30/09/20210.000.00-
31/12/20210.000.00-
31/03/20220.020.09+7bps
30/06/20220.060.21+15bps
30/09/20220.120.36+24bps
31/12/20220.210.51+30bps
31/03/20230.320.66+34bps
30/06/20230.420.77+35bps
30/09/20230.500.86+36bps
31/12/20230.570.93+36bps
MNI London Bureau | +44 203-865-3809 | edward.hardy@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.